Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women

Table 3 Distribution of HR-HPV types according to cervical intraepithelial neoplasia

	CC	CINI	CINII/CINIII	Total
	n (%)	n (%)	n (%)	Total
HPV16	9 (24.3%)	21 (56.7%)	7 (18.9%)	37
HPV18	8 (53.3%)	2 (13.3%)	5 (33.3%)	15
HPV31	0 (0.0%)	7 (100.0%)	0 (0.0%)	7
HPV33	0 (0.0%)	2 (100.0%)	0 (0.0%)	2
HPV35	2 (25%)	3 (37.5%)	3 (37.5%)	8
HPV39	0 (0.0%)	5 (100.0%)	0 (0.0%)	5
HPV45	4 (57.5%)	1 (14.2%)	2 (28.5%)	7
HPV51	0 (0.0%)	5 (83.3%)	1 (16.6%)	6
HPV52	0 (0.0%)	3 (100.0%)	0 (0.0%)	3
HPV53	3 (37.5%)	5 (62.5%)	0 (0.0%)	8
HPV56	0 (0.0%)	1 (100.0%)	0 (0.0%)	1
HPV58	2 (100.0%)	0 (0.0%)	0 (0.0%)	2
HPV59	3 (100.0%)	0 (0.0%)	0 (0.0%)	3
HPV66	2 (50.0%)	2 (50.0%)	0 (0.0%)	4
HPV68	1 (100.0%)	0 (0.0%)	0 (0.0%)	1
HPV70	0 (0.0%)	3 (100.0%)	0 (0.0%)	3

CINI cervical intraepithelial neoplasia I, CINII cervical intraepithelial neoplasia II, CINIII cervical intraepithelial neoplasia III

ISSN: 1750-9378